CRIS Current Research Information System

ROMANIELLO, DONATELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.613
EU - Europa 1.554
NA - Nord America 1.508
SA - Sud America 179
AF - Africa 57
OC - Oceania 3
Totale 5.914
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.481
IT - Italia 795
VN - Vietnam 744
SG - Singapore 740
CN - Cina 638
DE - Germania 154
HK - Hong Kong 154
BR - Brasile 142
FR - Francia 98
KR - Corea 92
IE - Irlanda 89
GB - Regno Unito 83
NL - Olanda 67
JP - Giappone 59
SE - Svezia 59
FI - Finlandia 54
IN - India 43
RU - Federazione Russa 41
AT - Austria 32
AR - Argentina 21
CI - Costa d'Avorio 21
ID - Indonesia 20
ES - Italia 19
TH - Thailandia 15
CA - Canada 13
BG - Bulgaria 12
PH - Filippine 12
TW - Taiwan 12
IQ - Iraq 11
MX - Messico 11
PL - Polonia 11
BD - Bangladesh 10
CH - Svizzera 10
JO - Giordania 10
SC - Seychelles 10
PK - Pakistan 9
DK - Danimarca 8
TG - Togo 8
ZA - Sudafrica 8
EC - Ecuador 7
SA - Arabia Saudita 7
TR - Turchia 7
IR - Iran 6
BE - Belgio 5
MY - Malesia 5
MA - Marocco 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
GR - Grecia 3
PY - Paraguay 3
RO - Romania 3
UA - Ucraina 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
IL - Israele 2
LB - Libano 2
LT - Lituania 2
NZ - Nuova Zelanda 2
AM - Armenia 1
AU - Australia 1
BF - Burkina Faso 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
CU - Cuba 1
DZ - Algeria 1
EG - Egitto 1
GH - Ghana 1
HR - Croazia 1
JM - Giamaica 1
LU - Lussemburgo 1
ML - Mali 1
PE - Perù 1
PT - Portogallo 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 5.914
Salva come PNG Salva come JPEG
Città #
Singapore 483
Bologna 393
Hefei 197
Ho Chi Minh City 195
Hanoi 188
Ashburn 179
San Jose 155
Hong Kong 144
Santa Clara 127
Chandler 112
Dublin 86
Seoul 83
Beijing 72
Princeton 70
Lauterbourg 66
Boardman 56
Dallas 51
Milan 46
Tokyo 44
Council Bluffs 43
Los Angeles 40
Berlin 37
Helsinki 36
Southend 36
Da Nang 32
Fairfield 32
Modena 30
Munich 28
Vienna 25
Rome 23
Amsterdam 22
Frankfurt am Main 22
London 22
Medford 22
Abidjan 21
Buffalo 21
Guangzhou 20
New York 20
Seattle 20
Haiphong 19
São Paulo 19
Nuremberg 18
Bengaluru 17
Redondo Beach 17
Shanghai 14
Brescia 13
Jakarta 13
The Dalles 13
Ninh Bình 12
Sofia 12
Lappeenranta 11
Orem 11
Amman 10
Can Tho 10
Hải Dương 10
Vũng Tàu 10
Woodbridge 10
Bern 9
Bremen 9
Chicago 9
Houston 9
Naples 9
Olalla 9
Düsseldorf 8
Florence 8
Jinan 8
Lomé 8
Marcon 8
Reggio Emilia 8
San Diego 8
Warsaw 8
Boydton 7
Bắc Giang 7
Cambridge 7
Falkenstein 7
Forlì 7
Redmond 7
Stanford 7
Thái Nguyên 7
Wilmington 7
Xi'an 7
Bangkok 6
Brooklyn 6
Turku 6
Alicante 5
Atlanta 5
Chengdu 5
Ferrara 5
Ha Long 5
Long An 5
Madrid 5
Montreal 5
Phoenix 5
Quận Ba 5
Quận Bình Thạnh 5
Taipei 5
Thu Dau Mot 5
Tianjin 5
Tongling 5
Toronto 5
Totale 3.824
Salva come PNG Salva come JPEG
Nome #
BMP7 promotes cardiomyocyte regeneration in zebrafish and adult mice 299
The natural sesquiterpene β- caryophyllene acts as an enviromental decontaminant through the interference with the STAT3 signalling pathway 252
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression 232
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy 215
A bispecific antibody targeting EGFR and AXL delays resistance to osimertinib 208
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation 200
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies 198
NF-kB oscillation profiles decode response to anti-EGFR monoclonal antibodies 197
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization 196
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 194
CEA Cell Adhesion Molecule 6 (CEACAM6), Collagen Type I Alpha 2 Chain (COL1A2), Galectin 4 (LGALS4) and Tetraspanin 8 (TSPAN8) mRNAs as blood biomarkers for colorectal cancer 194
Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies 190
PDL1 immunohistochemistry in canine neoplasms: Validation of commercial antibodies, standardization of evaluation, and scoring systems 179
NRG1/ERBB3/ERBB2 Axis Triggers Anchorage-Independent Growth of Basal-like/Triple-Negative Breast Cancer Cells 161
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 132
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab 129
ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma 129
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization 115
Senescence-associated reprogramming impairs response to EGFR neutralization 112
β-Caryophyllene Counteracts Chemoresistance Induced by Cigarette Smoke in Triple-Negative Breast Cancer MDA-MB-468 Cells 100
Targeting anaplastic lymphoma kinase in consensus molecular subtype 1 colon cancer patients 90
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 85
First-line therapy based on kinase inhibitors and antibodies prevents resistance in egfr-mutated lung cancer. 83
β-Hexachlorocyclohexane Drives Carcinogenesis in the Human Normal Bronchial Epithelium Cell Line BEAS-2B 82
CIRCADIAN DEPENDENT MOTILITY: THE ROLE FOR THE PERINUCLEAR ACTIN CAP 81
Senescence-associated reprogramming impairs response to EGFR neutralization 77
IL-1 in the microenvironment impairs response to EGFR- neutralization in CRC patients 76
Strategies to Overcome Resistance to Osimertinib in EGFR-Mutated Lung Cancer 76
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor 75
Comparative analysis of the interaction between different flavonoids and pdia3 74
Cancer Immunotherapy: The Dawn of Antibody Cocktails 73
Synergy Between Kinase Inhibitors And Antibodies Enables Upfront Prevention Of Recurring Secondary Resistance In Egfr-Mutated Lung Cancer 73
JAK2-Regulation Of HER2 “Addiction” In HER2-Positive Breast Cancer Cell Lines 73
Developing Comprehensive In Vitro and In Vivo Models: Patient-Derived Organoids (PDOs) and Xenografts (PDXs) for Morphological and Functional Analysis and Drug Screening in Head and Neck Squamous Cell Carcinoma 72
Biochemical characterization of the ERp57-STAT3 complex 71
An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors 69
Development of Head and Neck Squamous Cell Carcinoma Patient-Derived Xenografts (PDXs) and Organoids (PDXOs) for Morphological Analysis and Drug Screening 63
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models 62
STAT3 post-translational modifications drive cellular signaling pathways in prostate cancer cells 60
Dangerous liaison: organochlorine substances, energy metabolism and cancer 59
Analysis of stat3 post-translational modifications (ptms) in human prostate cancer with different gleason scores 58
Acetylation and phosphorylation of STAT3 are involved in the responsiveness of microglia to beta amyloid 57
Interaction between flavonoids and PDIA3 56
Functional Studies Of Stat3 And Its Interactors In Breast Cancer 55
STAT3--ERp57 Interplay in human prostate cancer 54
Protease, an Advance Therapeutic Target in Cancer 52
EGFR/STAT3/ERp57 Interplay in human prostate cancer progression 52
Circadian dependent motility: the role for the perinuclear actin cap 51
PARP-1 as coactivator of STAT3 in M14 melanoma cell line 50
A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways 49
STAT3/ERP57/TPX2 axis and process of “androgen escape” in prostate cancer 48
The Multifaceted Role of Growth Differentiation Factor 15 (GDF15): A Narrative Review from Cancer Cachexia to Target Therapy 47
null 46
Beyond EGFR inhibition in head and neck squamous cell carcinoma: Overcoming resistance mechanisms and novel therapeutic frontiers 46
Activation of ALK Signaling Pathway Induces DNA Damage Response in Colorectal Cancer 45
IL-1 in the microenvironment impairs response to EGFR- neutralization in CRC patients 45
STAT3-EGFR PATHWAY IN NEUROENDOCRINE PROSTATE CANCER: A CASE REPORT 44
STAT3's role in microglial cells 43
null 39
The ERBB Family of Receptor Tyrosine Kinases: Key Players in Cancer 33
Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies 8
null 4
Totale 6.088
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.468
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 3 1 4
2021/2022294 0 3 0 0 3 3 1 35 42 15 118 74
2022/2023624 53 58 24 55 70 50 16 59 124 10 54 51
2023/2024366 44 42 36 30 22 63 14 27 14 28 16 30
2024/20251.514 33 181 131 94 207 93 171 72 72 113 114 233
2025/20263.190 411 362 299 235 282 217 323 191 661 209 0 0
Totale 6.088